To enhance your user experience on our website, this site uses cookies.
If you continue to browse, you accept the use of cookies on our site.
See our Privacy Policy
for more information.
At the heart of this innovation lies the concept of synthetic gene circuits. Much like an electronic circuit, these biological systems are designed to sense specific signals within the tumor microenvironment (TME) and execute a programmed response. This technology often works in tandem with engineering cancer cells with targeted siRNA to silence the very genes that allow cancer cells to hide from the immune system.